RPL21P104

Across TCGA pan-cancer cohorts, RPL21P104 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RPL21P104 data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher RPL21P104 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPL21P104 expression acts as an unfavorable survival marker, although some lineages such as MESO and UCS show a favorable association.

DLBC, UVM, and STAD are the cancer types where RPL21P104 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Tertile	II,III,IV	0.159	0.801	.001	61	view →
UVM	OS	Tertile	III,IV	0.075	0.814	<.001	48	view →
STAD	DFS	Median	II,III,IV	0.280	0.469	.004	44	view →
MESO	DFS	Tertile	All	0.544	0.324	.010	36	view →
SKCM	DFS	Tertile	II,III,IV	0.364	0.582	.003	36	view →
KIRP	DFS	Tertile	III,IV	0.040	0.691	<.001	36	view →
UCS	DFS	Tertile	IV	0.996	0.522	.015	22	view →
TGCT	OS	Tertile	All	0.847	0.968	.033	18	view →
READ	OS	Tertile	IV	0.289	0.899	<.001	18	view →
LIHC	OS	Tertile	III,IV	0.059	0.738	<.001	18	view →
LUSC	OS	Tertile	II,III,IV	0.450	0.744	.017	10	view →
PAAD	OS	Tertile	All	0.205	0.469	.036	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RPL21P104–DLBC (OS)

Open the DLBC breakdown →